T1	dosage 1003 1017	dose-dependent
T2	interaction 1018 1045	attenuation of the response
T3	drug 1049 1061	dipyridamole
T4	interaction 1070 1102	significant negative correlation
T5	component 1123 1131	caffeine
T6	dosage 1149 1169	0, 1, 2, and 4 mg/kg
T7	drug 1179 1191	dipyridamole
T8	interaction 118 138	adenosine antagonist
T9	interaction 1192 1210	induced increments
T10	function 1214 1237	systolic blood pressure
T11	function 1251 1265	pulse pressure
T12	function 1279 1289	heart rate
T13	parameter 1307 1328	rate-pressure product
T14	function 1307 1320	rate-pressure
T15	component 1377 1385	caffeine
T16	interaction 1386 1396	attenuates
T17	component 139 147	caffeine
T18	drugEffect 1401 1421	hemodynamic response
T19	drug 1425 1437	dipyridamole
T20	mode 1438 1446	infusion
T21	population 1450 1456	humans
T22	dosage 1462 1476	dose-dependent
T23	interaction 15 25	inhibition
T24	component 1520 1528	caffeine
T25	interaction 1535 1560	pharmacologic interaction
T26	drugEffect 155 175	hemodynamic response
T27	drug 1630 1642	dipyridamole
T28	exam 1646 1677	thallium-201 myocardial imaging
T29	drug 179 191	dipyridamole
T30	mode 192 200	infusion
T31	dosage 202 211	0.4 mg/kg
T32	duration 212 225	for 4 minutes
T33	studyType 243 295	randomized, placebo-controlled double-blind protocol
T34	population 297 326	eight normotensive volunteers
T35	drugEffect 33 53	hemodynamic response
T36	drug 383 395	dipyridamole
T37	drug 415 427	dipyridamole
T38	mealTime 428 433	after
T39	dosage 434 451	1, 2, and 4 mg/kg
T40	component 452 460	caffeine
T41	mode 462 470	Infusion
T42	component 474 482	caffeine
T43	dosage 490 497	4 mg/kg
T44	interaction 499 506	induced
T45	interaction 510 518	increase
T46	function 522 544	mean arterial pressure
T47	drug 57 69	dipyridamole
T48	mode 625 633	Infusion
T49	drug 637 649	dipyridamole
T50	drugEffect 681 701	hemodynamic response
T51	interaction 710 718	increase
T52	function 722 745	systolic blood pressure
T53	component 73 81	caffeine
T54	function 768 782	pulse pressure
T55	function 805 815	heart rate
T56	parameter 846 870	calculated rate-pressure
T57	interaction 964 971	induced
T58	component 984 992	Caffeine
T59	interaction 993 1000	induced
A1	valence T45 Augmentation
A2	valence T4 NÃ©gation
A3	valence T16 Diminution
A4	valence T2 Diminution
A5	valence T51 Augmentation
R1	physiological_effect_antagonism Arg1:T58 Arg2:T3	
R2	physiological_effect_antagonism Arg1:T15 Arg2:T19	
